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Persistent organic pollutants (POPs) are a group 
of chemicals with common properties such as 
persistence, lipophilicity, and biomagnification 
in the food chain (Li et al. 2006). Lee et al. 
(2006b, 2007c) recently reported that serum 
concentrations of POPs were strongly associ-
ated with the prevalence of type 2 diabetes in 
the U.S. general population; this association 
was stronger among obese persons than among 
nonobese persons. Although dioxins have been 
widely studied as the most toxic chemical 
among POPs, organochlorine (OC) pesticides 
and polychlorinated biphenyl (PCB) conge-
ners, not dioxins, were strongly associated with 
type 2 diabetes. In particular, it was striking 
that when POPs concentrations were very low, 
prevalent type 2 diabetes was rare even among 
obese persons [body mass index (BMI) ≥ 30 
kg/m2]. Serum concentrations of these POPs 
were also associated with insulin resistance and 
adverse lipid profiles (Lee et al. 2007a, 2007b). 
Xenobiotics mainly bioaccumulate in adipose 
tissue; thus, all these findings raise the possibil-
ity that some POPs are critically involved in 
the pathogenesis of type 2 diabetes (Lee et al. 
2006a). However, because all these studies were 
cross-sectional, reverse causality, in which dia-
betes enhances POPs accumulation or inhibits 
their clearance, cannot be ruled out.
One recent study of a cohort of 471 Great 
Lakes sport fish consumers identified 36 inci-
dent cases of type 2 diabetes during follow-up 
examinations and demonstrated an association 
of incident diabetes with serum concentrations 
of 2,2-bis(4-chlorophenyl)-1,1-dichloroethene 
(p,p´-DDE), but not PCBs (Turyk et al. 2009). 
However, several prospective studies of selected 
POPS performed in occupational or accidental 
high-exposure settings reported inconsistent 
results, particularly for 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (2,3,7,8-TCDD) (Henriksen 
et al. 1997; Longnecker and Michalek 2000; 
Steenland et al. 1999). Furthermore, the 
decreasing trend of OC POPs during recent 
decades (Needham et al. 2005) is inconsistent 
with the current trend toward an increased 
prevalence of type 2 diabetes.
Considering these inconsistencies, we 
hypothesized that adverse metabolic effects due 
to POPs may occur more at low but persis-
tent exposures rather than at high exposures, 
for example, if the adverse effects were caused 
by endocrine disruption (Lee et al. 2006a). In 
fact, strong biological effects in low doses, but 
weak or no effects in higher doses (produc-
ing an inverted U-shaped graphic appearance) 
are proposed as possible biological responses 
to endocrine disruptors (Daston et al. 2003; 
Welshons et al. 2003). In this scenario, current 
background POPs serum concentrations could 
be even more biologically active than were the 
higher serum concentrations typically experi-
enced before many POPs were banned. If there 
were low-dose effects (rapid rise in risk across 
low doses, with flattened or even attenuated 
risk at higher doses), the failure to select a true 
reference group with very low concentrations 
of POPs would have distorted the true epide-
miological associations in high-exposure set-
tings, leading to inconsistent results (Henriksen 
et al. 1997; Longnecker and Michalek 2000; 
Steenland et al. 1999). Furthermore, the 
inverted U-shaped associations with biological 
outcomes typical of low-dose effects of endo-
crine disruptors would be missed under the 
assumption of a linear dose–response relation, 
which is often taken as a condition for estab-
lishing causality in epidemiological studies (Lee 
et al. 2006a).
We addressed the issues of temporal rela-
tion of exposure and disease and of possible 
low-dose, nonlinear associations in a prospec-
tive, nested case–control study of the relation-
ship between background exposure to certain 
POPs and the development of type 2 diabetes 
within the Coronary Artery Risk Development 
in Young Adults (CARDIA) study. Based on 
previous findings, we also hypothesized that we 
would find stronger associations with summary 
POPs measures than with individual POPs and 
that these associations would be stronger among 
obese persons than among nonobese persons.
Materials and Methods
Source population. CARDIA cohort study 
focused on the development of cardiovascular 
Address  correspondence  to  D.R.  Jacobs  Jr., 
University of Minnesota, Division of Epidemiology 
and Community Health, School of Public Health, 
1300 South 2nd St., Suite 300, Minneapolis, MN 
55454 USA. Telephone: (612) 624-4196. Fax: (612) 
624-0315. E-mail: jacob004@umn.edu
Supplemental  Material  is  available  online 
(doi:10.1289/ehp.0901480 via http://dx.doi.org/).
This study was supported by the National Heart, 
Lung, and Blood Institute [contracts N01-HC-48047, 
N01-HC-48048, N01-HC-48049, N01-HC-48050 
(CARDIA field centers), N01-HC-95095 (CARDIA 
Coordinating Center), and grant R01-HL-53560 
(YALTA)].
The authors declare they have no actual or potential 
competing   financial interests.
Received 21 September 2009; accepted 5 May 2010.
Low Dose of Some Persistent Organic Pollutants Predicts Type 2 Diabetes: 
A Nested Case–Control Study
Duk-Hee Lee,1 Michael W. Steffes,2 Andreas Sjödin,3 Richard S. Jones,3 Larry L. Needham,3 and David R. Jacobs, Jr.4,5
1Department of Preventative Medicine, School of Medicine, Kyungpook National University, Daegu, Korea; 2Department of Laboratory 
Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA; 3Organic Analytical Toxicology 
Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, 
Georgia, USA; 4Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA; 5Department 
of Nutrition, University of Oslo, Oslo, Norway
Ba c k g r o u n d: Low doses of some persistent organic pollutants (POPs) associate cross-sectionally 
with type 2 diabetes, whereas associations with high POP exposures are inconsistent.
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Using serum collected in 1987–1988, we measured 8 organochlorine pesticides, 22 polychlorinated 
biphenyl congeners (PCBs), and 1 polybrominated biphenyl (PBB). We compared POP concentra-
tions from CARDIA and the National Health and Nutrition Examination Survey (NHANES) in 
2003–2004. We computed odds ratios (ORs) for incident diabetes using logistic regression analysis. 
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disease risk among participants who were 
18–30 years old. The study design, recruit-
ment of participants, and methods have been 
described in detail elsewhere (Friedman et al. 
1988). In brief, 5,115 African-American and 
white participants were recruited at baseline 
in 1985–1986 (year 0); follow-up examina-
tions were completed at years 2, 5, 7, 10, 15, 
and 20 (2005–2006) for 91%, 86%, 81%, 
79%, 74%, and 72%, respectively, of survi-
vors. Institutional review board approval at 
each site and informed consent were obtained 
at every examination.
Prior to blood collection at year 2, partici-
pants were asked to fast for at least 12 hr. The 
serum samples that were collected and stored at 
this time (1987–1988) were used to measure 
POPs. Individuals were eligible for the current 
study if they had had no diagnosis of diabetes 
at years 0 and 2 and if they had been diagnosed 
with type 2 diabetes at any subsequent exami-
nation. Diabetes was defined as ever having 
taken antidiabetic medications or ever having 
had fasting glucose ≥ 126 mg/dL at two or 
more examinations. After 18 years of follow-up 
116 persons had been diagnosed with type 2 
diabetes; of these, 90 were randomly selected as 
cases. Control subjects were randomly selected 
by assigning a random number (distributed 
uniformly between 0 and 1) to each participant 
who had fasting glucose < 100 mg/dL at all 
five examinations (years 0, 7, 10, 15, and 20) 
when glucose was measured. We frequency 
matched the controls to cases using the follow-
ing year 0 BMI strata: < 20, 20–24.9, 25–29.9, 
30–39.9, and ≥ 40 kg/m2; within each stratum 
we selected those participants who had the low-
est random number until the desired number 
of participants was reached.
We also used the National Health and 
Examination Survey (NHANES) 2003-2004 
to compare serum concentrations of POPs 
between CARDIA subjects and current con-
centrations in the U.S. general population. 
NHANES is an ongoing survey designed 
to measure the health and nutritional sta-
tus of the civilian noninstitutionalized U.S. 
population [Centers for Disease Control and 
Prevention (CDC) 2010].
Measurements. Data on demographic vari-
ables, health behaviors, anthropometric data, 
and various clinical variables were measured at 
baseline and at follow-up examinations. Blood 
samples were collected after an overnight fast. 
BMI was derived from measured height and 
weight (kilograms per meter squared). Clinical 
variables included fasting glucose, triglycer-
ides, and total cholesterol. The protocols for 
lipid and glucose determinations can be found 
elsewhere (Jacobs et al. 1999).
POPs analyses. POPs were measured 
in serum samples (stored at Solomon Park 
Research Laboratories, Seattle, WA, USA) col-
lected at year 2 (stored frozen at –70°C until 
analysis). The samples were analyzed by a pre-
viously published methodology (Sjodin et al. 
2004) involving solid-phase extraction and final 
determination using gas chromatography iso-
tope dilution high-resolution mass spectrom-
etry (GC/ID-HRMS). The GC/ID-HRMS 
analysis was performed on a MAT95XP 
(ThermoFinnigan MAT, Bremen, Germany) 
instrument. The chromatographic separations 
were carried out on a 6890N gas chromato-
graph (Agilent Technologies, Atlanta, GA) at 
the CDC in Atlanta, GA, USA. Laboratory 
personnel were masked to all CARDIA data, 
including case–control status. A total of 55 
POPs were measured: 9 OC pesticides, 35 PCB 
congeners, 10 polybrominated diphenyl ether 
(PBDE) congeners, and 1 polybrominated 
biphenyl (PBB) congener [see Supplemental 
Material, Table 1 (doi:10.1289/ehp.0901480)].
Statistical methods. Lipid-standardized con-
centrations, the concentrations of serum POPs 
divided by total serum lipid content (milli-
grams per deciliter) calculated as 2.2 × serum 
cholesterol (milligrams per deciliter) + serum 
tri  glycerides (milligrams per deciliter) + 62.3 
(Phillips et al. 2008), have generally been 
reported in epidemiological studies, because 
POPs are predominantly carried in the lipid 
component of the blood. In addition, lipid-
standardized concentration has been regarded 
as better reflecting body burden than wet-
weight concentrations (Lopez-Carrillo et al. 
1999). However, if certain POPs disturb lipid 
metabolism as we previously observed (Lee 
et al. 2007b), wet-weight (i.e. unadjusted) 
concentrations should be examined because 
lipid concentrations may be intermediate in a 
causal chain linking POPs and type 2 diabe-
tes (Howard 1999; Schisterman et al. 2005). 
Furthermore, according to a simulation study 
conducted by Schisterman et al. (2005), 
wet-weight concentrations adjusting for tri-
glycerides and total cholesterol had less bias 
than did lipid-  standardized concentrations. 
Thus, we present in this study wet-weight con-
centrations, and wet-weight concentrations 
adjusting for triglyceride and total cholesterol 
by including these two lipid profiles in the 
models as confounders. Findings using lipid-
standardized concentrations are also provided 
in Supplemental Material, Tables 2 and 3 
(doi:10.1289/ehp.0901480) for comparison.
We performed all analyses using SAS 9.1   
(SAS Institute Inc., Cary, NC USA) to mea-
sure individual POPs and summary POPs. In 
the individual analyses, study subjects were 
categorized in quartiles of the distribution 
among controls of each POP. We included 
only measurements with more than 75% of 
values above the detection limit (31 POPs: 
8 OC pesticides, 22 PCBs, and 1 PBB con-
geners) in the analyses; thus, subjects with 
nondetectable or low concentrations belonged 
to the lowest quartile of each POP.
We formed summary POPs measures by 
applying three rationales. The first summary 
measure combined all 31 POPs examined in 
the current study. The second measure was 
based on both prior cross-sectional findings 
(Lee et al. 2006b, 2007c) and the findings for 
individual POPs presented in this paper. For 
example, of the 12 POPs that were signifi-
cantly associated with type 2 diabetes in previ-
ous cross-sectional studies, Lee et al. (2006b, 
2007c) showed that 8 POPs (trans-nonachlor, 
oxychlordane, PCB74, PCB153, PCB170, 
PCB180, PCB187, and BB153) had the high-
est risk in the second quartile, although most 
failed to reach statistical significance in indi-
vidual analyses. We hypothesized a priori that 
this low-dose effect was present because serum 
concentrations of the current study subjects 
were much higher than were those in previ-
ous cross-sectional studies (Lee et al. 2006b, 
2007c). Among the remaining 19 POPs that 
were newly included in the current study, 
8 POPs also showed similar low-dose effects. 
Considering these findings in individual 
analyses, we included in the second summary 
each POP that showed an odds ratio (OR) 
≥ 1.5 in the second quartile in lipid-adjusted 
analyses in the present study. A summary 
that included POPs that showed OR ≥ 1.7 
in any quartile yielded similar results and is 
therefore not shown. The third rationale for 
forming other summary measures was to use 
underlying biologic mechanisms that were 
suggested by others. For instance, McFarland 
and Clarke (1989) proposed PCB groupings 
by enzyme induction potential of cytochrome 
P450 subfamilies, whereas Wolff et al. (1997) 
classified them by estrogenic and neurotoxic, 
antiestrogenic (aryl hydrocarbon-receptor 
agonists, dioxin-like), and enzyme-inducing 
phenobarbital-type cytochrome P450 types.
In the summary analyses, we summed 
the individual ranks of several POPs. For 
example, in the case of POPs with no non-
detectable values, the lowest concentration 
of a given POP was assigned rank 0, and the 
highest was assigned rank 179. For another 
particular POP for which 10 samples had val-
ues below LOD, subjects with concentrations 
below LOD were assigned rank 0, and the 
remaining 170 POPs were ranked by concen-
tration, 10 for the lowest concentration and 
179 for the highest concentration. The ranks 
for each POP were added, and summed values 
were divided into four categories (quartiles) or 
six categories (sextiles) in analyses that pro-
gressively traded sample size for lower POPs 
concentrations in the reference category.
ORs and 95% confidence intervals (CIs) 
for the risk of type 2 diabetes were estimated 
using logistic regression. The possible con-
founders included age (continuous), sex, race, 
and BMI (continuous) at year 2 in analyses of 
POPs wet weights; triglycerides (continuous) Persistent organic pollutants and diabetes
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and total cholesterol (continuous) at year 2 
were added in POPs lipid-adjusted analyses. 
The confounders were known risk factors of 
type 2 diabetes and also may be associated 
with serum concentrations of POPs. We pres-
ent p for trend, p for quadratic term, or p for 
cubic term, representing each category by its 
median value (median values of serum con-
centrations for individual POPs measures and 
median ranks for summary POPs measures). 
The quadratic model allows the outcome 
curve to rise and then fall (as in an inverted 
U shape), whereas the cubic model would 
allow the outcome curve to rise, then to fall, 
then to rise again. We further examined if 
there were multiplicative interactions between 
individual sums of POPs (median ranks for 
sextiles) and obesity (< 30 vs. ≥ 30 kg/m2) on 
the risk of diabetes. Given the small sample 
size, we considered p < 0.05 as significant and 
p < 0.1 as borderline significant.
Results
The average age of participants, both cases 
and controls, at year 2 was 27 years (Table 1). 
Cases had a higher proportion of men and a 
lower proportion of whites than did controls. 
Although the control distribution of BMI was 
frequency matched to the case distribution of 
BMI at year 0, mean BMI difference between 
cases and controls expanded by year 2. After 
BMI matching, we found significantly higher 
fasting triglycerides and glucose among cases 
than among controls, whereas high-density lipo-
protein (HDL) cholesterol was correspondingly 
lower among cases. Low-density lipo  protein 
(LDL) cholesterol was not significantly different 
between cases and controls at baseline.
Most POPs concentrations, particularly 
OC pesticides, were much higher among the 
CARDIA participants assessed in 1987–1988 
than among NHANES subjects assessed in 
2003–2004 at 20–36 years old, which rep-
resents the age range of CARDIA partici-
pants at year 2 in 1987–1988. The POPs in 
CARDIA were also higher when compared 
with NHANES participants age 36–52 years 
(the age range that CARDIA participants had 
achieved in 2003–2004). Importantly, the sec-
ond quartile POPs concentrations in the cur-
rent population were similar to those in the 
highest quartile in the NHANES subjects. 
However, most PBDEs were not detectable 
in CARDIA subjects, whereas PBDEs were 
detectable in NHANES subjects, suggesting 
recent exposure to PBDEs (Table 2).
Tables 3–5 present two models for predict-
ing incident diabetes from individual POPs and 
their summations: unadjusted lipid (model 1) 
and adjusted lipid (model 2). Most p-values 
for individual POPs failed to reach statistical 
significance. However, some individual POPs 
displayed statistically significantly higher ORs 
of diabetes in the second quartile compared 
Table 1. Baseline characteristics of CARDIA subjects.
Characteristic Control (n = 90) Case (n = 90) p-Value
Age at year 2 (years) 27.2 ± 3.3 27.2 ± 3.6 0.91
Percent men 31.1 45.6 0.05
Percent white 51.1 31.1 < 0.01
BMI (kg/m2)
Year 0 28.4 ± 6.1 29.6 ± 6.4 0.19
Year 2 29.1 ± 6.7 30.9 ± 6.6 0.07
Triglycerides (mg/dL)
Year 0 74.1 ± 46.7 94.6 ± 65.1 0.02
Year 2 78.4 ± 46.4 110.2 ± 70.9 < 0.01
HDL cholesterol (mg/dL)
Year 0 53.2 ± 13.5 47.5 ± 12.9 < 0.01
Year 2 53.2 ± 13.7 45.7 ± 12.2 < 0.01
LDL cholesterol (mg/dL)
Year 0 113.1 ± 21.8 116.2 ± 32.0 0.52
Year 2 111.5 ± 32.9 118.6 ± 32.1 0.15
Fasting glucose (mg/dL)
Year 0 79.8 ± 6.0 86.1 ± 10.6 < 0.01 
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein. Tabulated values are mean ± SD.







Data set 1 2 3 4
Oxychlordane
CARDIA 1987–1988 20–36 99.4 ≤ 110 111–157 158–200 > 200
NHANES 2003–2004 20–36 72.6 — ≤ 30 31–52 > 52
NHANES 2003–2004 36–52 92.1 ≤ 46 47–70 71–108 > 108
trans-Nonachlor
CARDIA 1987–1988 20–36 100 ≤ 109 110–174 175–250 > 250
NHANES 2003–2004 20–36 98.6 ≤ 27 28–51 52–88 > 88
NHANES 2003–2004 36–52 98.5 ≤ 61 62–101 102–169 > 169
β-Hexachlorocyclohexane
CARDIA 1987–1988 20–36 98.3 ≤ 75 76–108 109–146 > 146
NHANES 2003–2004 20–36 54.4 — ≤ 19 20–34 > 34
NHANES 2003–2004 36–52 79.7 ≤ 22 23–43 44–70 > 71
p,p´-DDE
CARDIA 1987–1988 20–36 100 ≤ 2,153 2,154–3,312 3,313–5,731 > 5,731
NHANES 2003–2004 20–36 99.6 ≤ 462 463–759 760–1,275 > 1,275
NHANES 2003–2004 36–52 100 ≤ 846 847–1,444 1,445–3,035 > 3,035
Mirex
CARDIA 1987–1988 20–36 75 — ≤ 21 22–34 > 34
NHANES 2003–2004 20–36 15.1 — — — —
NHANES 2003–2004 36–52 51.7 — — ≤ 32 > 32
PCB74
CARDIA 1987–1988 20–36 100 ≤ 58 59–98 99–144 > 144
NHANES 2003–2004 20–36 100 ≤ 11 12–15 16–22 > 22
NHANES 2003–2004 36–52 100 ≤ 22 23–31 32–48 > 48
PCB153
CARDIA 1987–1988 20–36 100 ≤ 204 205–349 350–466 > 466
NHANES 2003–2004 20–36 100 ≤ 37 38–55 56–89 > 89
NHANES 2003–2004 36–52 100 ≤ 106 107–155 156–231 > 231
PCB178
CARDIA 1987–1988 20–36 95.6 ≤ 8 9–15 16–21 > 21
NHANES 2003–2004 20–36 74.4 ≤ 1 2–3 4–5 > 5
NHANES 2003–2004 36–52 97.7 ≤ 6 7–9 10–13 > 13
PCB187
CARDIA 1987–1988 20–36 100 ≤ 44 45–78 79–104 > 104
NHANES 2003–2004 20–36 98.4 ≤ 6 7–11 12–19 > 19
NHANES 2003–2004 36–52 97.2 ≤ 23 24–35 36–54 > 54
PBB153
CARDIA 1987–1988 20–36 100 ≤ 9 10–16 17–23 > 23
NHANES 2003–2004 20–36 78.0 ≤ 3 4–9 10–17 > 17
NHANES 2003–2004 36–52 88.7 ≤ 10 11–18 19–34 > 34
—, nondetectable. 
aCARDIA control subjects (n = 90) were categorized by quartile. bPercentile values in NHANES were computed to 
account for the NHANES complex survey design. Dashes indicate undetectable concentrations. Lee et al.
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with the first quartile, particularly before lipid 
adjustment. The results for individual POPs 
should be carefully interpreted with regard to 
effects of lipid adjustment, because POPs may 
promote dyslipidemia (so the lipid adjustment 
could be an overadjustment).
Among 8 OC pesticides, trans-nonachlor 
showed the strongest association with the risk 
of future diabetes (p for quadratic term = 0.06) 
(model 2 in the Table 3). Subjects in the sec-
ond quartile had four times higher risk of 
developing type 2 diabetes compared with 
those in the lowest quartile. Oxychlordane and 
mirex also showed about two times higher risk 
in the second quartile, but these associations 
did not achieve statistical significance.
Among PCB congeners, highly chlo-
rinated PCBs with seven or eight chlorides 
tended to show the highest risk in the second 
quartile with adjusted ORs of 2–3 (Table 4). 
Among moderately chlorinated PCBs, PCB74, 
PCB146, and PCB153 showed a high risk for 
type 2 diabetes in the second quartile. PBB153 
also showed a higher risk for type 2 diabetes in 
the second or third quartiles (Table 4). On 
the other hand, we found marginally signifi-
cant trends for PCB105, PCB194, PCB195, 
PCB196–203, and PCB209. However, the 
inverse trend was due to a decreased risk in 
third and fourth quartiles after adjusting 
for lipid profiles. PCB194, PCB195, and 
PCB196–203 still showed the highest risk in 
the second quartile despite the inverse trends.
We examined associations of the sum of 
POPs with incident type 2 diabetes. The sum-
mary measure with all 31 POPs showed an 
inverted U-shaped pattern, in particular in sex-
tile analysis (Table 5; Figure 1). The increased 
risk in the last sextile disappeared after lipid 
adjustment. Because it is unlikely that all POPs 
would be equally involved in the association 
with incident diabetes, we further examined a 
second, more selective summary measure with 
POPs with ≥ 1.5 OR in the second quartile in 
the analyses of individual POPs and observed 
stronger associations at low serum concen-
trations than those of all 31 POPs (Table 5). 
When we used sextiles, the adjusted OR of 
the second sextile was 5.4 (95% CI, 1.6–18.4, 
model 2) and the risk decreased as the sum-
mary score increased, making an inverted 
U-shaped association. Because the highest risk 
was observed below the median summary score 
and because there was some tendency for risk 
to increase in the highest category, compared 
with next highest category in model 1 without 
lipid adjustment, p for cubic trend was more 
significant than p for quadratic trend in model 
1. As was true for all 31 POPs, we found that 
the increased risk in the highest sextile disap-
peared after lipid adjustment.
We also examined several groupings of 
PCB congeners classified by biological char-
acteristics (Table 5). Using McFarland and 
Clarke’s classification (1989), we found that 
phenobarbital-type inducers and weak or non-
inducers of CYP 450 showed low-dose effects, 
whereas mixed-type inducers did not show any 
association. Using the classification developed 
by Wolff et al. (1997), we found that PCBs 
belonging to group 1B (estrogenic, weak phe-
nobarbital-type inducers, persistent) or group 
2B (antiestrogenic and immunotoxic, dioxin-
like, persistent) showed the strongest low-dose 
effects. Based on findings using this classifica-
tion, the most notable common property of 
PCBs that was associated with type 2 diabetes 
was persistency of PCBs, rather than estrogenic 
or dioxin-like activity.
When study subjects were stratified using 
a BMI cut point of 30 kg/m2, p-values for 
multiplicative scale interaction within logis-
tic regression using product terms were mar-
ginally significant (p for interaction = 0.06) 
for the summary measure with 16 selected 
POPs with ≥ 1.5 OR in the second quartile. 
In accordance with our prior hypothesis, the 
inverted U-shaped association was evident 
only among subjects with BMI ≥ 30 kg/m2 
for all 31 POPs and for 16 selected POPs 
(Figure 2). With the summary measure of 16 
selected POPs with ≥ 1.5 ORs in the second 
quartile, compared with the lowest sextile, 
the risk in the second sextile was 21.2 times 
higher among those with BMI ≥ 30 kg/m2.
Discussion
In this nested case–control study, we found that 
some POPs (in particular, trans-  nonachlor and 
highly chlorinated PCBs) among the CARDIA 
participants at year 2 were associated with inci-
dent type 2 diabetes for the next 18 years, espe-
cially among obese persons. However, POPs 
did not show a traditional dose–response rela-
tion with diabetes. Instead POPs showed strong 
associations at relatively low exposure, mak-
ing inverted U-shapes. These nonlinear shapes 
were anticipated, at least insofar as we discussed 
these possibilities in our previous cross-sectional 
studies on POPs (Lee et al. 2006a). In fact, the 
cohort study performed in Great Lakes Sport 
Fish Consumers, which included only 36 cases 
of incident diabetes, did not show the inverted 
U-shaped association in their main results 
(Turyk et al. 2009). However, low-dose effects 
were suggested among younger and heavier per-
sons in their study, as in our study subjects (M 
Turyk, personal communication).
The inverted U-shaped associations have 
been proposed as possible biological responses 
of endocrine disruptors (Daston et al. 2003; 
Welshons et al. 2003), unlike the traditional 
Table 3. Adjusted ORs of incident diabetes according to quartiles of OC pesticides.
Quartiles
1 2 3 4
Oxychlordane
Case–control 13/22 30/23 16/22 31/23
Model 1 Reference 2.0 (0.8–5.0) 1.3 (0.4–3.7) 2.6 (1.0–7.0)
Model 2 Reference 1.7 (0.7–4.3) 1.1 (0.4–3.4) 1.4 (0.5–4.4)
trans-Nonachlor
Case–control 7/22 33/23 22/22 28/23
Model 1 Reference 4.8 (1.7–13.7) 2.7 (0.9–8.3) 3.7 (1.2–11.0)
Model 2 Reference 4.3 (1.5–12.6) 2.3 (0.7–7.4) 2.0 (0.6–6.9)
Hexachlorobenzene
Case–control 25/22 18/23 21/22 26/23
Model 1 Reference 0.7 (0.3–1.7) 0.9 (0.4–2.3) 1.4 (0.6–3.5)
Model 2 Reference 0.5 (0.2–1.3) 0.7 (0.3–1.9) 1.0 (0.4–2.6)
β-Hexachlorocyclohexane
Case–control 22/22 23/23 19/22 26/23
Model 1 Reference 1.2 (0.5–3.0) 1.2 (0.5–3.2) 1.4 (0.5–3.4)
Model 2 Reference 1.0 (0.4–2.5) 0.9 (0.3–2.5) 0.8 (0.3–2.2)
γ-Hexachlorocyclohexane
Case–control 19/22 21/23 24/22 26/23
Model 1 Reference 1.2 (0.5–3.0) 1.2 (0.5–3.0) 1.3 (0.5–3.1)
Model 2 Reference 1.2 (0.5–3.0) 1.1 (0.4–2.8) 1.3 (0.5–3.2)
p,p’-DDE
Case–control 18/22 23/23 30/22 19/23
Model 1 Reference 1.3 (0.5–3.3) 1.6 (0.7–3.9) 0.9 (0.3–2.4)
Model 2 Reference 1.2 (0.5–3.0) 1.3 (0.5–3.4) 0.7 (0.2–1.9)
p,p´-DDT
Case–control 17/22 16/23 25/22 32/23
Model 1 Reference 0.9 (0.3–2.2) 1.3 (0.5–3.3) 1.3 (0.5–3.3)
Model 2 Reference 0.8 (0.3–2.2) 1.0 (0.4–2.5) 0.9 (0.3–2.6)
Mirex
Case–control 16/29 18/16 21/22 35/23
Model 1 Reference 2.1 (0.8–5.5) 1.5 (0.6–3.7) 2.1 (0.8–5.1)
Model 2 Reference 2.0 (0.7–5.5) 1.4 (0.5–3.7) 1.8 (0.7–4.9)
Model 1: adjusted for age, sex, race, and BMI at year 2. Model 2: further adjustment for triglyceride and total cholesterol 
at year 2.Persistent organic pollutants and diabetes
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paradigm of cellular toxicity in which there 
is a linear dose–response relation. POPs are 
well-known endocrine disruptors (Vasseur and 
Cossu-Leguille 2006). Hormones act indirectly 
through binding to specific receptors. In many 
biological systems, there is a linearity of dose 
and receptor occupancy only up to a dose that 
occupies about 10% of receptors. At higher 
doses, the effect of a higher occupancy rate does 
not increase linearly as the dose of the hormone 
increases (Daston et al. 2003; Welshons et al. 
2003). Furthermore, a linear biological response 
is observed only at doses that result in the low-
est range of receptor occupancy (Daston et al. 
2003; Welshons et al. 2003). In high-dose hor-
mone exposure, there is even downregulation of 
receptors as the dose further increases (Medlock 
et al. 1991). Thus, high doses of hormonally 
active chemicals can exert inhibitory effects on 
processes that are stimulated at much lower 
doses, which result in inverted U dose–response 
curves. Although endocrine disruption is an 
example of a biological system that could lead 
to low-dose response, we do not have specific 
evidence that endocrine disruption explains 
these epidemiologic observations.
At present, there is little knowledge 
about the biological mechanisms that might 
link POPs and type 2 diabetes. Although 
aryl hydrocarbon receptor (AhR) affinity has 
been the main focus in relation to POPs tox-
icity (Nebert et al. 1993), PCBs with some 
affinity to AhR (PCB105, PCB118, and 
PCB156) were not clearly associated with 
the risk of type 2 diabetes. Thus, mechanisms 
other than AhR affinity may be involved in the 
pathogenesis of type 2 diabetes. In addition, 
when we analyzed PCBs using the classification 
of Wolff et al. (1997), we found that groupings 
of both estrogenic PCBs and antiestrogenic 
PCBs showed low-dose effects. Thus, estroge-
nicity, at least in the Wolff et al. (1997) formu-
lation, does not explain the link between PCBs 
and diabetes. In the analyses, using the clas-
sification of McFarland and Clarke, (1989), we 
found that PCBs in a grouping of phenobarbi-
tal-type inducers and in another grouping of 
weak or noninducers of CYP 450 showed the 
Congener (no. of chlorine  
or bromine atoms)
Quartiles
1 2 3 4
PCB74 (4)
Case–control 17/22 33/23 16/22 24/23
Model 1 Reference 2.8 (1.1–7.5) 1.4 (0.5–4.0) 2.6 (0.9–7.1)
Model 2 Reference 2.8 (1.0–7.3) 0.9 (0.3–2.6) 1.4 (0.5–4.5)
PCB87 (5)
Case–control 22/22 18/22 25/23 25/23
Model 1 Reference 1.0 (0.4–2.5) 1.3 (0.5–3.1) 1.0 (0.4–2.4)
Model 2 Reference 1.1 (0.4–2.8) 1.1 (0.5–2.9) 0.6 (0.2–1.6)
PCB99 (5)
Case–control 21/22 18/23 22/22 29/23
Model 1 Reference 0.8 (0.3–2.0) 1.1 (0.5–2.8) 1.3 (0.5–3.2)
Model 2 Reference 0.7 (0.3–1.8) 0.8 (0.3–2.1) 0.8 (0.3–2.0)
PCB105 (5)
Case–control 28/21 18/24 22/22 22/23
Model 1 Reference 0.5 (0.2–1.2) 0.8 (0.3–2.1) 0.6 (0.2–1.6)
Model 2 Reference 0.3 (0.1–0.8) 0.5 (0.2–1.4) 0.2 (0.1–0.8)
PCB118 (5)
Case–control 26/22 18/23 24/22 22/23
Model 1 Reference 0.6 (0.2–1.6) 1.1 (0.5–2.8) 0.8 (0.3–2.1)
Model 2 Reference 0.5 (0.2–1.3) 0.7 (0.3–1.8) 0.5 (0.2–1.4)
PCB146 (6)
Case–control 14/22 32/22 17/23 27/23
Model 1 Reference 2.2 (0.9–5.7) 1.1 (0.4–3.1) 1.7 (0.6–4.6)
Model 2 Reference 1.7 (0.7–4.5) 0.8 (0.3–2.4) 0.9 (0.3–2.6)
PCB153 (6)
Case–control 15/22 35/23 14/22 24/23
Model 1 Reference 2.4 (1.0–6.1) 0.8 (0.3–2.5) 1.6 (0.6–4.4)
Model 2 Reference 2.0 (0.8–5.2) 0.6 (0.2–1.9) 0.8 (0.2–2.6)
PCB156 (6)
Case–control 17/21 29/24 20/22 24/23
Model 1 Reference 1.7 (0.7–4.3) 1.1 (0.4–3.1) 1.6 (0.6–4.7)
Model 2 Reference 1.3 (0.5–3.5) 0.9 (0.3–2.6) 0.8 (0.2–2.9)
PCB157 (6)
Case–control 20/21 29/23 21/23 20/23
Model 1 Reference 1.2 (0.5–3.1) 0.7 (0.3–1.9) 1.0 (0.3–2.9)
Model 2 Reference 1.0 (0.4–2.5) 0.5 (0.2–1.5) 0.5 (0.1–1.7)
PCB138–158 (6)
Case–control 20/23 26/22 17/22 27/23
Model 1 Reference 1.4 (0.6–3.5) 0.8 (0.3–2.2) 1.4 (0.5–3.4)
Model 2 Reference 1.2 (0.5–2.9) 0.6 (0.2–1.6) 0.8 (0.3–2.2)
PCB167 (6)
Case–control 24/22 23/23 25/22 18/23
Model 1 Reference 1.1 (0.5–2.6) 1.3 (0.5–3.1) 0.9 (0.3–2.2)
Model 2 Reference 0.9 (0.4–2.2) 1.0 (0.4–2.5) 0.5 (0.2–1.3)
PCB170 (7)
Case–control 13/22 35/23 18/22 24/23
Model 1 Reference 2.7 (1.0–7.1) 1.1 (0.4–3.3) 1.9 (0.6–5.9)
Model 2 Reference 2.2 (0.8–6.1) 0.8 (0.2–2.6) 0.9 (0.3–3.4)
Congener (no. of chlorine  
or bromine atoms)
Quartiles
1 2 3 4
PCB178 (7)
Case–control 14/22 38/23 11/21 27/24
Model 1 Reference 3.2 (1.3–8.2) 0.7 (0.2–2.2) 2.0 (0.7–5.5)
Model 2 Reference 2.7 (1.0–7.0) 0.5 (0.2–1.7) 1.0 (0.3–3.2)
PCB180 (7)
Case–control 12/22 41/23 13/22 24/23
Model 1 Reference 3.4 (1.3–9.0) 0.9 (0.3–2.8) 2.0 (0.6–6.4)
Model 2 Reference 2.8 (1.0–7.6) 0.7 (0.2–2.5) 1.1 (0.3–3.9)
PCB183 (7)
Case–control 15/22 31/23 18/22 26/23
Model 1 Reference 1.9 (0.8–4.8) 1.3 (0.5–3.4) 1.5 (0.6–3.9)
Model 2 Reference 1.7 (0.7–4.2) 1.0 (0.3–2.7) 0.8 (0.3–2.3)
PCB187 (7)
Case–control 12/22 41/23 8/22 29/23
Model 1 Reference 3.2 (1.2–8.2) 0.5 (0.2–1.8) 1.9 (0.7–5.4)
Model 2 Reference 2.8 (1.1–7.4) 0.5 (0.1–1.6) 1.0 (0.3–3.3)
PCB194 (8)
Case–control 16/22 32/23 23/22 19/23
Model 1 Reference 2.0 (0.8–5.1) 1.2 (0.4–3.3) 1.1 (0.3–3.4)
Model 2 Reference 1.6 (0.6–4.3) 0.8 (0.2–2.4) 0.4 (0.1–1.5)
PCB195 (8)
Case–control 15/22 34/22 17/23 24/23
Model 1 Reference 2.3 (0.9–5.9) 1.0 (0.4–2.9) 1.3 (0.5–3.8)
Model 2 Reference 1.9 (0.7–5.1) 0.8 (0.3–2.2) 0.6 (0.2–1.9)
PCB199 (8)
Case–control 16/22 35/23 14/22 25/23
Model 1 Reference 2.3 (0.9–5.8) 0.9 (0.3–2.5) 1.6 (0.5–4.6)
Model 2 Reference 2.2 (0.8–5.6) 0.7 (0.2–2.3) 0.9 (0.3–3.0)
PCB196–203 (8)
Case–control 15/22 39/23 13/22 23/23
Model 1 Reference 2.8 (1.1–7.0) 0.8 (0.3–2.4) 1.5 (0.5–4.3)
Model 2 Reference 2.3 (0.9–6.1) 0.6 (0.2–1.9) 0.6 (0.2–2.2)
PCB206 (9)
Case–control 20/22 19/23 29/22 22/23
Model 1 Reference 0.9 (0.3–2.2) 1.3 (0.5–3.4) 0.9 (0.3–2.5)
Model 2 Reference 0.7 (0.3–1.9) 1.0 (0.4–2.7) 0.5 (0.1–1.6)
PCB209 (10)
Case–control 16/19 35/26 15/22 24/23
Model 1 Reference 1.6 (0.6–4.1) 0.6 (0.2–1.8) 0.9 (0.3–2.7)
Model 2 Reference 1.1 (0.4–3.0) 0.3 (0.1–1.1) 0.4 (0.1–1.3)
PBB153 (6) 
Case–control 10/22 29/23 26/22 25/23
Model 1 Reference 3.0 (1.1–8.1) 3.1 (1.1–9.2) 2.6 (0.9–7.9)
Model 2 Reference 2.5 (0.9–6.9) 2.5 (0.8–7.6) 1.8 (0.6–5.8)
Table 4. Adjusted ORs of incident diabetes according to quartiles of PCB or PBB. 
Model 1: adjusted for age, sex, race, and BMI at year 2. Model 2: further adjustment for triglyceride and total cholesterol at year 2. Lee et al.
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low-dose effects, whereas groupings of PCBs 
that were mixed-type inducers were not associ-
ated with type 2 diabetes. Interestingly, PCBs 
in the grouping of mixed-type inducers have 
been traditionally regarded as having the great-
est toxic potential compared with other PCBs. 
Therefore, our data suggest that neither an AhR 
affinity nor estrogenicity explain the association 
between PCBs and type 2 diabetes. Rather, 
chronic exposure with weak or little-known 
toxicity may play a role in the pathogenesis of 
type 2 diabetes, given that highly chlorinated 
PCBs tend to be more persistent in the envi-
ronment than PCBs with fewer chlorines. In 
the absence of known biological mechanism(s) 
and demonstrated low-dose effects of POPs 
on type 2 diabetes, our grouping of individual 
POP analyses, coupled with the consistency of 
our results with previous findings for preva-
lent diabetes (Lee et al. 2006b, 2007c), can 
be justified to create summary POPs measures 
based on results of individual POP analyses.
For valid estimation of relative risks to 
detect the presence of low-dose effects, a ref-
erence group is required with extremely low 
concentrations of relevant POPs so that low 
risk is uniform across values within the refer-
ence group. However, a true reference group 
without any exposure to POPs does not exist 
in the general population (i.e., in epidemio-
logical data). In general, serum concentrations 
of POPs tend to be highly correlated with each 
other because of the simultaneous exposure 
to various POPs through food consumption, 
but the correlations are not perfect. Given 
these correlations, the reference group used 
in the analysis of an individual POP would 
have the lowest concentration of that specific 
POP but could have higher concentrations 
of other POPs that had a higher risk of type 
2 diabetes. Therefore, in the presence of low-
dose effects of POPs, the contamination of the 
reference group of specific POPs with higher 
concentrations of other important POPs may 
lead to an artificial increase of risk within the 
reference group of the specific POP, leading 
to underestimated risk relative to this group. 
In this situation, a summary POPs measures 
formed by summing individual ranks of the 
POPs, for example, those 16 POPs with ORs 
of ≥ 1.5 in the second quartile in individual 
analyses, facilitates selecting a reference group 
with extremely low concentrations of those 
POPs that are relevant to a risk of type 2 dia-
betes. We acknowledge that such a summary 
measure may to some extent overestimate 
ability to predict type 2 diabetes because it is 
data driven; however, this tendency is coun-
tered by the fact that several of the 16 POPs 
selected for analysis in this study were based 
Table 5. Adjusted ORs of incident diabetes according to quartiles or sextiles of summary measures of POPs.
Quartile/sextile 1 2 3 4 5 6 pquadratic pcubic
All 31 POPs in Tables 3 and 4
Quartile
Model 1 Reference 1.9 (0.8–4.5) 1.0 (0.4–2.5) 1.2 (0.5–3.2) 0.47 0.14
Model 2 Reference 1.4 (0.5–3.5) 0.7 (0.2–1.9) 0.5 (0.1–1.5) 0.22 0.33
Sextile
Model 1 Reference 2.9 (1.0–8.8) 4.8 (1.5–14.8) 1.5 (0.4–4.8) 1.9 (0.6–4.8) 2.7 (0.8–8.8) 0.20 0.03
Model 2 Reference 2.8 (0.9–8.7) 3.7 (1.1–12.3) 1.2 (0.4–4.2) 1.3 (0.4–4.8) 1.0 (0.2–4.3) 0.04 0.10
16 POPs with OR ≥ 1.5 in the second quartile in Tables 3 and 4
trans-Nonachlor, oxychlordane, mirex, PCB74, PCB146, PCB153, PCB170, PCB178, PCB180, PCB183, PCB187, PCB194, PCB195, PCB199, PCB196–203, PBB 153
Quartile
Model 1 Reference 3.4 (1.4–8.7) 1.1 (0.4–3.0) 1.6 (0.6–4.3) 0.14 0.01
Model 2 Reference 2.8 (1.1–7.2) 0.8 (0.3–2.3) 0.7 (0.2–2.2) 0.05 0.04
Sextile
Model 1 Reference 5.9 (1.8–19.3) 4.3 (1.3–13.9) 2.0 (0.6–7.0) 1.4 (0.4–5.2) 3.9 (1.1–13.9) 0.41 < 0.01
Model 2 Reference 5.4 (1.6–18.4) 3.4 (1.0–11.4) 1.6 (0.4–5.8) 1.0 (0.3–4.1) 1.4 (0.3–6.3) 0.10 < 0.01
McFarland and Clark (1989) groupings
Group 1B (mixed-type inducers: PCB105, PCB118, PCB156, PCB170)
Sextile
Model 1 Reference 1.0 (0.3–2.9) 1.0 (0.3–2.9) 2.1 (0.7–6.5) 1.0 (0.3–3.0) 1.4 (0.4–4.2) 0.76 0.91
Model 2 Reference 0.9 (0.3–2.8) 0.8 (0.3–2.6) 1.4 (0.4–4.6) 0.5 (0.2–1.9) 0.7 (0.2–2.5) 0.58 0.90
Group 2 (phenobarbital-type inducers: PCB87, PCB99, PCB153, PCB180, PCB183, PCB194)
Sextile
Model 1 Reference 2.1 (0.7–6.4) 2.5 (0.8–7.5) 1.0 (0.3–3.2) 1.2 (0.4–3.8) 1.6 (0.5–5.0) 0.43 0.08
Model 2 Reference 2.0 (0.7–6.4) 2.0 (0.6–6.2) 0.9 (0.3–3.0) 0.7 (0.2–2.5) 0.6 (0.2–2.4) 0.12 0.17
Group 3 (weak or noninducers: PCB74, PCB187)
Sextile
Model 1 Reference 1.1 (0.4–3.4) 3.7 (1.2–11.4) 1.9 (0.6–5.8) 1.3 (0.4–4.3) 2.0 (0.6–6.3) 0.21 0.34
Model 2 Reference 1.0 (0.3–3.2) 2.9 (0.9–9.3) 1.4 (0.4–4.8) 0.9 (0.3–3.0) 0.9 (0.2–3.5) 0.12 0.50
Wolff et al. (1997) groupings
Group 1B (estrogenic, weak phenobarbital-type inducers, persistent: PCB187)
Sextile
Model 1 Reference 2.8 (0.8–8.5) 3.2 (1.0–9.7) 1.0 (0.3–3.2) 1.2 (0.4–3.9) 2.7 (0.8–8.9) 0.79 < 0.01
Model 2 Reference 2.4 (0.8–7.9) 2.8 (0.8–8.9) 0.8 (0.2–2.7) 0.8 (0.2–3.0) 1.1 (0.3–4.4) 0.35 0.02
Group 2A (antiestrogenic, immunotoxic, dioxin-like, moderately persistent: PCB74, PCB105, PCB118, PCB156, PCB167)
Sextile
Model 1 Reference 0.9 (0.3–2.5) 0.7 (0.2–2.1) 1.6 (0.5–5.0) 0.8 (0.2–2.4) 0.9 (0.3–2.9) 0.93 0.59
Model 2 Reference 0.8 (0.3–2.5) 0.5 (0.2–1.7) 0.9 (0.3–3.1) 0.4 (0.1–1.3) 0.5 (0.1–1.8) 0.93 0.96
Group 2B (antiestrogenic and immunotoxic, dioxin-like, persistent: PCB170)
Sextile
Model 1 Reference 3.2 (1.0–10.1) 3.1 (1.0–9.7) 1.3 (0.4–4.2) 1.2 (0.3–4.3) 2.9 (0.8–10.3) 0.65 < 0.01
Model 2 Reference 2.8 (0.9–9.1) 2.5 (0.8–8.3) 0.9 (0.3–3.4) 0.9 (0.2–3.4) 1.2 (0.3–5.2) 0.31 0.02
Group 3 (phenobarbital-type inducers, persistent: PCB99, PCB153, PCB180, PCB183)
Sextile
Model 1 Reference 1.6 (0.6–4.9) 1.8 (0.6–5.4) 0.9 (0.3–2.7) 1.1 (0.3–3.5) 1.8 (0.6–5.9) 0.93 0.12
Model 2 Reference 1.5 (0.5–4.6) 1.5 (0.5–4.6) 0.7 (0.2–2.3) 0.8 (0.2–2.7) 0.8 (0.2–3.1) 0.64 0.26
Model 1: wet-weight model, adjusted for age, sex, race, and BMI at year 2. Model 2: lipid-adjusted model 1 with further adjustment for triglycerides and total cholesterol at year 2.Persistent organic pollutants and diabetes
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on a priori selection of POPs that were found 
to be important in previous studies (Lee et al. 
2006b, 2007c).
In contrast, although the summary measure 
of all 31 POPs is not data driven, it can com-
promise our effort to select subjects with very 
low concentrations of relevant POPs as the 
reference group. For example, some subjects in 
the lowest sextile of the summary measure of 
all 31 POPs were those with very low concen-
trations of the irrelevant POPs but relatively 
high concentrations of the 16 POPs with ORs 
of ≥ 1.5 in the second quartile. In this case, the 
risk of diabetes in the reference group, based on 
the sum of all 31 POPs, would increase and the 
OR estimates would be biased toward the null, 
compared with using the reference group based 
on the sum of the 16 selected POPs. The true 
association of selected POPs with diabetes risk 
likely lies between the estimates based on these 
two summary measures. Whichever summary 
measure we used, the ORs detected were large, 
particularly among the obese participants, so 
the findings as presented give a good idea of 
the size and shape of the association of certain 
POPs with incident diabetes.
In this study, another important strategy 
to reduce POPs level in the reference group 
was to categorize in sextiles. This strategy 
could have the drawback of leading to too 
many categories in a study with a relatively 
small sample size. In fact, our study showed 
that the associations became stronger when we 
refined the lowest category by expanding from 
quartiles to sextiles.
One critical question about exposure assess-
ment is whether lipid standardization of POPs 
is valid in epidemiological studies. In a pre-
vious study, Lee et al. (2006a) reported that 
OC pesticides and PCBs were associated with 
dyslipidemia; that is, increased triglycerides and 
decreased HDL cholesterol. Our findings in 
this study also suggest that some POPs may 
disturb lipid metabolism over the extended 
period of observation; these findings will be 
reported in a separate paper. As dyslipidemia is 
an early manifestation of conditions character-
ized by insulin resistance and is often detect-
able before the development of postprandial 
or fasting hyperglycemia (Lewis et al. 2002), 
lipid concentrations may be intermediaries 
in the associations between POPs and type 2 
diabetes. In this case, any form of adjustment 
for circulating lipid concentrations would sub-
stantially underestimate true risk associations. 
However, although it can be overadjustment to 
control for baseline lipid concentrations, find-
ings not adjusted for lipids can be underad-
justed, because POPs are carried by lipid in the 
blood. In fact, the effect of lipid adjustment was 
most strongly observed in the highest sextile of 
POPs, which consisted of subjects with a broad 
range of particularly high lipid concentrations. 
The highest category tended toward increased 
ORs before lipid adjustment, but this tendency 
mostly disappeared after lipid adjustment. The 
true associations between the POPs studied and 
incident diabetes may lie between the estimates 
with and without lipid adjustment.
Another important methodological issue 
is that a single exposure assessment provides 
an imprecise picture of POPs exposure. In 
this study, serum was sampled up to 18 years 
before the diabetes diagnosis. Although POPs 
Figure 1. Adjusted ORs and 95% CIs of incident diabetes according to sextiles of the summary measure 
formed from serum concentrations of all 31 POPs (Σ31POPs; A) or 16 selected POPs [Σ16POPs; B) (trans-
nona  chlor + oxychlordane + mirex + PBB153 + 12 PCBs) with ORs ≥ 1.5 in the second quartile in Tables 3 and 
4. Lipid-adjusted model, that is, adjusted for age, sex, race, BMI, triglycerides, and total cholesterol at year 2. 
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Figure 2. Adjusted ORs and 95% CIs of incident diabetes according to sextiles of the summary measure 
formed from serum concentrations of all 31 POPs (Σ31POPs; A, B) or 16 selected POPs (Σ16POPs; C, D) 
(trans-nonachlor + oxychlordane + mirex + PBB153 + 12 PCBs) with ORs ≥ 1.5 in the second quartile in 
Tables 3 and 4 stratified by year 2 BMI. Lipid-adjusted model, that is, adjusted for age, sex, race, BMI, tri-
glycerides, and total cholesterol at year 2.














S1 S2 S3 S4 S5 S6 S1 S2 S3 S4 S5 S6
S1 S2 S3 S4 S5 S6 S1 S2 S3 S4 S5 S6




























Σ16POPs Σ16POPsLee et al.
1242  v o l u m e  118 | n u m b e r 9 | September 2010  •  Environmental Health Perspectives
have long half-lives, body burden of POPs can 
change substantially during follow-up. Because 
the development of diabetes requires deteriora-
tion of glucose metabolism over the long term, 
prolonged and persistent exposure to POPs 
may be an important factor in a putative causal 
pathway linking POPs and diabetes. Because we 
measured POPs only once, we could not assess 
whether their concentrations changed during 
follow-up. In fact, chlorinated POP concen-
trations at year 2 in these CARDIA subjects 
(1987–1988, recognizing that they had higher 
BMI than the general CARDIA sample) were 
much higher than those in the current U.S gen-
eral population—a finding that suggests that 
chlorinated POPs concentrations in serum of 
CARDIA subjects primarily reflect the body 
burden accumulated during the calendar time 
before banning chlorinated POPs in the 1970s. 
Based on the comparison with NHANES par-
ticipants at current CARDIA ages, current 
concentrations of chlorinated POPs, not bro-
minated POPs such as PBDEs, in our partici-
pants would be lower than at year 2. However, 
we also believe that the slow clearances of POPs 
over many years differ among people, and we 
hypothesize that the rank of POPs concentra-
tions of the participants may have changed 
during follow-up. It is thought that there are 
interindividual and chemical-specific variations 
in excretion of POPs (Thomaseth and Salvan 
1998; Wolff et al. 1997).
As most chlorinated POPs have already 
been banned and body burdens are decreasing, 
research interest has tended to focus on more 
recently introduced POPs such as PBDEs. 
However, the strong low-dose effects of chlo-
rinated POPs observed here imply that their 
low persistent exposures throughout the body 
may be a problem well into the future as the 
banned POPs slowly clear, passing through 
perhaps more dangerous lower concentrations. 
In addition, obesity seemed to exaggerate met-
abolic disturbance related to POPs, with the 
result that in the midst of the ongoing obesity 
epidemic, the currently low POPs concentra-
tions may be a potent health risk.
This study has several limitations. First, the 
sample size was a compromise related to the 
practicalities of cost and the use of precious 
samples. Therefore, most analyses based on 
individual POPs failed to reach statistical sig-
nificance in terms of p for trend or p for qua-
dratic term, although some ORs in the second 
quartile showed statistical significance. Second, 
the data analyses involved a large number of 
statistical tests; therefore, some of the individ-
ual statistically significant findings may have 
occurred by chance. In this study, we focused 
our interpretation more on consistency than 
on statistical significance. Third, under the 
low-dose effect, the selection of a reference 
group with very close to zero POP concentra-
tions is critical to   unbiased assessment of the 
risk of adverse health outcomes. Combining 
study subjects across apparently low ranges 
of POPs can lead to a reference group with 
artificially increased risk and diluted relative 
risk estimates. As the CARDIA subjects in 
1987–1988 had higher values of chlorinated 
POPs than present in the NHANES studies in 
2003–2004, we cannot exclude the possibility 
that some risk gradient was still masked in our 
CARDIA subgroup, even when we used the 
lowest control group sextile to approximate 
more closely a true zero risk reference group 
in our nested case–control study. Finally, we 
could not exclude the possibility that other 
POPs not measured in this study could play 
a role in the pathogenesis of type 2 diabetes, 
because serum concentrations of POPs are 
highly correlated in the general population.
In conclusion, the results from this study 
suggest that environmental exposure to some 
POPs may increase, in a nonlinear fashion, 
the risk of future type 2 diabetes in the general 
population. Various POPs, which mainly accu-
mulate in adipose tissue, may play a critical role 
in the current epidemic of type 2 diabetes.
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